These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7924573)

  • 1. Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
    Wu H; Zhao HY
    Chin Med J (Engl); 1994 May; 107(5):342-6. PubMed ID: 7924573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A research of acute hemodynamics and hormonal changes of intravenous captopril in patients with cor pulmonale and pulmonary hypertension].
    Tang B; Cheng Z; Huang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):303-5, 319. PubMed ID: 8762486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical study of intravenous captopril in heart failure].
    Wu H; Zhao HY
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):161-4. PubMed ID: 8222978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J; Lalonde G; Bichet D; Rouleau JL
    Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
    Mager G; Steffen HM; Klocke RK; Wambach G; Kux A; Degenhardt S; Höpp HW; Hilger HH
    Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic changes during captopril inhibition of the renin-angiotensin-aldosterone system in patients with circulatory failure following heart valve prosthesis].
    Anokhin VN; Vladimirov PV; Marshutin NA; Migalina LA; Zenkov VE
    Revmatologiia (Mosk); 1988; (2):43-8. PubMed ID: 3051276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Captopril in the treatment of refractory cardiac insufficiency].
    Gorb IuG
    Ter Arkh; 1985; 57(12):63-7. PubMed ID: 3911466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W; Halawa B
    Pol Merkur Lekarski; 1997 Sep; 3(15):105-8. PubMed ID: 9461703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal effects of captopril in chronic heart failure].
    Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
    Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone and haemodynamic effects of angiotensin II infusion during captopril treatment for heart failure.
    Chambers S; Nicholls MG; Espiner EA; Ikram H; Livesey JH
    Horm Metab Res; 1985 Mar; 17(3):159-62. PubMed ID: 2987094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.